Inclisiran: A Novel Agent for Lowering Apolipoprotein B-Containing Lipoproteins.
Sign Up to like & getrecommendations! Published in 2021 at "Journal of cardiovascular pharmacology"
DOI: 10.1097/fjc.0000000000001053
Abstract: ABSTRACT Hypercholesterolemia is a leading cause of cardiovascular morbidity and mortality. Accordingly, efforts to lower apolipoprotein B-containing lipoproteins in plasma are the centerpiece of strategies for cardiovascular prevention and treatment in primary and secondary management.… read more here.
Keywords: novel agent; lowering apolipoprotein; containing lipoproteins; inclisiran novel ... See more keywords